Reduced lung function is an independent risk factor for the development of impaired glucose tolerance?

T. Yamane, A. Yokoyama, N. Shiota, H. Ohnishi, N. Hattori, N. Kohno (Nangoku City, Hiroshima City, Japan)

Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD
Session: Comorbidities and impact on society of asthma and COPD
Session type: Poster Discussion
Number: 1759
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Yamane, A. Yokoyama, N. Shiota, H. Ohnishi, N. Hattori, N. Kohno (Nangoku City, Hiroshima City, Japan). Reduced lung function is an independent risk factor for the development of impaired glucose tolerance?. Eur Respir J 2011; 38: Suppl. 55, 1759

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The link between impaired lung function and increased cardiovascular risk
Source: Annual Congress 2009 - Epidemiology of COPD and infectious lung diseases
Year: 2009


Inadequate glucose control in type 2 diabetes is associated with impaired lung function and with systemic inflammation
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009


High airway responsiveness as a risk factor for lung function decline
Source: Annual Congress 2010 - Airway responsiveness, chronic cough and bronchiectasis: a modern approach
Year: 2010

Endothelial dysfunction is associated with impaired lung function in two independent community cohorts
Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function
Year: 2018

Hypoxia effect on the hepatic profile, glucose metabolism and cardiovascular risk.
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018


Decreased pulmonary function tests are affected by blood glucose tolerance
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020

Peripheral insulin resistance accounts for impaired glucose tolerance and is associated with systemic inflammation in COPD
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011

Impaired lung function is associated with systemic inflammation and macrophage activation
Source: Eur Respir J 2015; 45: 557-559
Year: 2015


Prevalence of abnormal lung function and age-dependent risk factors in the general population
Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Year: 2019



Increased serum placenta growth factor level is significantly associated with progression, recurrence and poor prognosis of lung cancer
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012

Elevated C-reactive protein is associated with reduced lung function and exercise capacity in normal subjects. Are we born inflammed?
Source: Eur Respir J 2006; 28: Suppl. 50, 331s
Year: 2006

Predicting an accelerated lung function decline in smokers: is there a proper threshold?
Source: Eur Respir J 2014; 43: 307-308
Year: 2004


Predicting an accelerated lung function decline in smokers: is there a proper threshold?
Source: Eur Respir J 2014; 43: 308-309
Year: 2004


Factors affecting early adult lung function
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019

Clinical parameters and biomarkers for the early detection of impaired glucose tolerance in OSA patients
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012


Metabolic syndrome, systemic inflammation and Framingham risk score are independent risk factors for reduced lung function in healthy Korean adults
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013

Pre-COVID-19 lung function and other risk factors for severe COVID-19 in first responders
Source: ERJ Open Res, 7 (1) 00610-2020; 10.1183/23120541.00610-2020
Year: 2021



The role of TRAP exposure in the development and persistence of asthma and low lung function
Source: International Congress 2017 – Asthma from childhood to adulthood and ACOS
Year: 2017

Risk factors and biomarkers of low lung function in early adulthood in the Lifelines study
Source: Virtual Congress 2021 – Asthma burden and management I
Year: 2021


Is smoking an independent prognostic factor of pulmonary function (PF) alteration after lobectomy?
Source: Eur Respir J 2006; 28: Suppl. 50, 273s
Year: 2006